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• Regional Varlatlo,, In Aiigloplaaty Practice In the 
United States: A Report From the Hlmlog 
Angioplasty Study 
John A. Bitti, Waqar H. Abroad, Robert N. Plan& John StTony, Burt Adalman, 
Peter Ganz, Andrew P. Selwyn~ Brigham & Woman's Hospital, Boston, MA 
The diagnosis of unstable angina (UA) Comprises vad0us ¢tinicel features 
having a wide range of risk for adverse outcomes. Geographic variations 
in cardiac treatmsnt exist in the U.S., but variations in the use of PTCA for 
UA have not been reported, 3641 of 40~8 patients (89%) enrolled in the 
HirulOg Angiopiasty Study were f~m U.S. census regions: (1) New England, 
(2) Mid-Atlantic, (3) South Atlantic, (4) Ea~,t Central, (5) West Central, and (6) 
West. NI patients undergoing PTCA had UA (new-onset, crescendo or rest 
pain), but the proportion of patients undergoing~ PTCA for high-risk clinical 
features, or for only mild lesions (-~ 50% by quantitative angiography) varied 
sharply acrosS regions: 
R~ion 1 2 3 4 5 6 P 
n 467 581 1026 576 55t 440 
Post-MI (%) 24.2 17.2 18.2 13.5 20,6 16.1 0.001 
Rest pain (%) 7"/.9 69.7 67.3 50.9 64,6 59.~ < O.gO1 
Prior hoparin (%) 50.9 35.6 42.3 32.3 35.9 39.4 < 0.00'f 
Mild lesions (%) 4.3 7.1 8.2 6.4 7.1 4.3 0.03 
~i  i qO~S (~) 3. 4 3"1 lll 4.9 5,6 4,4 6.7 0.07 
Thus, patients in New England have more rest pain, more post-MI angina, 
and fewer lesions of debatable Significance. Nevertheless, these higher~sk 
patients have the ssm~ rate of cOmpliCations (death, MI, CABG) as those 
in other regions. The relation between the use of PTCA for UA and clinical 
outcomes requires urgent study. 
ANGIOPLASTY - RESTENOSIS -  BASIC 
~ Endovescular Radiation Reduces Vsacu;ar Lesion 
Formation (VLF) After Balloon Injury (Bit of Pig 
Coronary Arteries by Inhibiting Cell Prol.'~.erstion 
lion Waksman, Keith A. Robinson, Neal A. Scott, Ion R, Crocks:, Spencer 
B. King III, Cheryl E. Ross, Gusta.vo D. Clpolle, Josiah N. Wilcox. Emory 
University Schcof of Medicine Atlanta GA 
Ionizing radiation (IR) has been shown to reduce (VLF) following (BI) of 
pig coronary arteries. To determine the mechanism by which IR reduces 
VLF, BI was performed on the LAD, LCX, and RCA artedes of 22 pigs. 
Immediately following BI, a flexible catheter with a pure beta emitter g0 SR/Y 
was introduced to deliver 14 or 28 Gy (to a depth of 2 ram) into 14 of the 
injured arteries, Animals were killed 3 and 7 days alter injury. 5-Bromo-2- 
deoxyuddins (Brdu) was administered 24 hours before sasdfice to label the 
proliferating coils. Immunohistoct]emistry was performed on frozen sections 
with monoclonal antibodies to Brdu and the number of Brdu positive cells 
relative to the total number of cells was determined using computer-based 
image analysis. Cell proliferation was significantly reduced by 3 days alter BI 
in the media and advantitia of irradiated vessels. There was no evidence of 
cell death and necrosis in artedes exposed to IR. Alpha actin staining used 
as an index of vascular emodeling appear to be lower in the advantitia of 
the irradiated vessels. 
% of Brd~ Control 14 Gy 26 Gy 
,LabpIIn,g 3 days 7 days 3 days 7 days .... 3 days 7 days 
Adventltla 28.1 9.6 18.6" 8.0 7.1** 3.4 
Media 14,4 4.6 7,6" 5.3 8,1 8.2 
*p - o.o4 versus control 3days, *'p < 0.0003 versus control 3days 
Conclusions: These studies suggest that enclovascular radiation reduces 
VLF by inhibiting the first wave of cell proliferation i  the advantitia nd the 
media. 
~ Tissue Factor Pathway Inhibitor Attenuates 
Prothromblnase Complex Formation on 
Balloon-lnjursd Arteries in Pigs 
Lu-ying Yang, James St, Pierre, Galen Kam, Daryl Thornton, 
Paul Eisenberg, Dana Abendschein. Washington Univ., St. Louis, fifo 
We have shown that intravenous infusion of tissue factor pathway inhibitor 
(TFPI), the physiologic inhibitor of factor Xa and tissue factor/factor Vile, 
essentially abolishes stenosis measured 4 wk after balloon-induced carotid 
arterial injury in minipigs. To determine whether the effect of TFPI on stenosis 
is associated with eady decreases in proccagulant activity and thrombosis 
on the luminal surface, we injured both carotid artedes by balloon hyper- 
irfflatians in 27 anesthetized pigs given either TFPI (0.5 mg/kg bolus and 
100/~g/kg/min, I.v., n = 10) or heparin (200 U/kg bolus and 100 U/kgJll, n 
= 17) as a control for 24 h. Indium-111-tsbeled autolegous platelets were 
Injected I h before collection of the arledes within 24 h for measurement 
of thrombosis. Injured artedal segments were incubated with ohromogenic 
su'ostrate for assay of factor Xa ($2222) and perfusod with recalP..,itied human 
plasma for assay Of fibdnopoptide A (FPA) in the eluant to measure the 
rate of thrombin-mediated flbdn fon nation, Ptsta!et deposition trended to be 
higher on arterias from a.nimals given TFPt compared to those given heparin 
(p = 0.06). However, factor Xa activity was 4-fold lower on TFPI-treatsd ar- 
redes compared with hepadn-trestod arteries (p = 0.0t2). In addition, FPA 
generation in the eloant after 10 rain was reduced on TFPl-~aaiad (222 .~ 
72 (SE) ng/ml) co .mp~red v,;,'ith,, hepadn-treated arteries (1503 ~: 376 ~g/ml, 
p = 0.004). Thus, while pl=eist deposition was not attenuated, prethrembi. 
nass complex and the resulting procoagulant activity of the luminal surface 
ware diminished substantially by TFPI. We condede that promising resuits 
with TFPI in the porcine angiopiasty model ikely result from dec~'easad lec~ 
thrombin gsnera~on. 
ANGIOPLASTY-  RESTENOSIS  - CL IN ICAL 
~ Endovascular Low Dose Radiation for  Prevention 
of Restenosis Following Ang]oplasty for  Treatment 
of Narrowed Dialysis Arterlo venous uralts 
Ron Waksman, lan R. Crocker, Deepak Kiked, Alan B. Lumsden, Julia 
M, MacDonald, Janice Long, Spencer B. King III, Louis G. Martin. Division 
of Cardiology, Radiation Onco/ogy, Nephrofogy, Vascular Surgery, Vascular 
/nteNantfonal Radiofogy of Emery University School of Medicine Atlanta GA 
Failure of artedo-venous grafts (AVG) of chronic dialysis patients remains 
a problem despite repeated balloon angloplasty (PTA). The purpose of this 
study was to determine whether low dose intravescular adiation therapy 
following PTA will retard neointimal hyperplasia in patients who have failed 
conventional balloon PTA for stanoais at the AVG. Eleven patients underwent 
PTAto 14 narrowed (> 50% luminal stanoais) dialysis AVG sites. Alter obtain= 
ing a good angiographic result and reduction of pressure gradient a delivery 
catheter was placed at the angispiasty site, and intravascular adiation was 
calibrated to a dose of 14 Gy at a depth of 2 mm to the artedal wall. The patient 
was then treated with a high activity Io21ddium line source ¢lalivered to the 
treatment site by a high dose rate altedcader. All patients treated had good 
angingraphio results post angleplasty and successful delivery of the radiation 
treatment into the AVG Without complications. Dudng mean follow-up of 164 
± 36 days at monthly intervals, ultrasound revealed patent and functioning 
AVG for dialysis in 13 out of 14 grafts. One patient had graft thrombosis three 
months alter the procedure. Conciu:;ions: Intravascutar adiation following 
balloon angioplasty to narrowed AVG ih ebmnie dialysis patients is feasible 
and may reduce the restenosis rate and extend the survival of these grafts, 
~ Local DmgDativery of Low Molecular Weight 
Nepsrin After PTCA: First Clinical Experience 
Using the Porous Balloon (PILOT-Study) 
Martin Oberhalf, Thomas Hermann, Rita Meier, Anastasios Athanaaledis, 
Andreas Baumbanh, Christian Hardeg, Armin Bohnet, Karl K. Hesse, 
Wolfram Voelker, Kad R. Karscb, Division of Cardiology, University of 
TObingen, Germany 
Aim of this trial was to assess the safety ~ld elficacy of lOcal drug delivery 
(LDD) of low molecular weight heparin Revipadn (Knoll Inc., Ludwigshafan, 
Germany) using a porous balloon to prevent restenosis after PTCA. 
The 2,7 mm porous balloon (SI III, ACS, CA, USA} used in this study had 
35 holes in a spiral pattern (hole diameter of 75 p.m). Fifteen patients (male 
n = 9, female n = 6, age 61 -4- 8 years) undergoing successful PTCA (LAD n 
= 10, RCX n = 3, RCA n = 2) were treated locally With Reviparin {1500 anti- 
Xa-units/4 ml, 2 elm) and during the following 24 hours with additional 10500 
anti-Xa-units Revipadn intravenously. For the following 28 days the patlents 
received further 7000 anti-Xa.units Revipadn subcutaneously. Angiograms 
were obtained before and alter PTCA, alter LDD and after 24 hours, 
The primary device success rats was 100%. Quantitative coronary an- 
giogrephy showed a minimal uminal diameter of 0.43 -4- 0.08 mm before 
PTCA, 1,79 -~ 0,29 turn alter PTCA, 1.57 4- 0.25 mm after LDD and 1.59 
0.30 mm alter 24 hours, No major complication (e.g. myocardial infarction, 
bleeding complications, bypass surgery or death) occurred dudng the 28 
days follow-up-padod. 
Conclusion: The initial results of this ongoing trial suggest, that local drug 
del:.=ry with low molecular weight hepadn using the porous balloon after 
PTCA is feasible and safe. Data on restenosis will be available at the 6 
months angiegrephic and clinical follow up. 
